Ernst-Günter Afting
Direktor/Vorstandsmitglied bei BioMedCredit AG
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bruce Carter | M | 80 | 11 Jahre | |
| Jay Luly | M | 67 | 21 Jahre | |
| Lesley Russell | M | 63 | 8 Jahre | |
| Paul Mellett | M | 68 | 21 Jahre | |
| Jaisim Shah | M | 63 | 11 Jahre | |
| Terry Vance | M | 67 | 13 Jahre | |
| Yat Sun Or | M | 72 | 25 Jahre | |
| Michael C. Woodford | M | 64 |
Olympus Europa GmbH
 Olympus Europa GmbH Medical DistributorsDistribution Services Part of Olympus Corp., Olympus Europa GmbH is a German company that creates customer-driven solutions for the medical, life sciences, and industrial equipment industries. The company is based in Hamburg, Germany and operates in dozens of countries all over the world. The company offers a comprehensive lineup of solutions for early diagnosis and minimally invasive therapy for a range of diseases. | - |
| Rudolf Wehrli | M | 75 |
BioMedCredit AG
 BioMedCredit AG Investment ManagersFinance BioMedCredit AG provides capital in the form of repayable, interest-bearing loans to small- and mid-sized private companies in Switzerland. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bill Welch | M | 62 | 4 Jahre | |
| Dirk van den Boom | M | 53 | 18 Jahre | |
| Hubert Köster | M | - | 4 Jahre | |
| Kenneth Buechler | M | 70 | 7 Jahre | |
| Antonius P. Schuh | M | 59 | 5 Jahre | |
| Helmut Schühsler | M | 65 | 10 Jahre | |
| Reinhard Kandera | M | 54 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 12 Jahre |
| Thomas Lingelbach | M | 60 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 7 Jahre |
| Gregory Verdine | M | 65 | 18 Jahre | |
| Spiros Jamas | M | 63 | 3 Jahre | |
| Ronald M. Lindsay | M | 76 | 13 Jahre | |
| Douglas J. Langston | M | 63 | 3 Jahre | |
| Harry Hixson | M | 84 | 12 Jahre | |
| R. William Bowen | M | 71 | - | |
| Marc Goldberg | M | 67 | 12 Jahre | |
| Glenn Halpryn | M | 63 | 4 Jahre | |
| Lawrence Rosen | M | 66 |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | 23 Jahre |
| John A. Fazio | M | 80 | 8 Jahre | |
| Alexander Ullrich von Gabain | M | 73 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 16 Jahre |
| William S. Marth | M | 69 | - | |
| Curtis Lockshin | M | 64 | 4 Jahre | |
| Marcy Graham | F | 57 | - | |
| Nathaniel Gardiner | M | 70 | 29 Jahre | |
| Utz-Hellmuth Felcht | M | 76 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | 19 Jahre |
| Cam Gallagher | M | 54 | 2 Jahre | |
| George Golumbeski | M | 67 | 7 Jahre | |
| Justin File | M | 53 | 2 Jahre | |
| David R. Webb | M | 79 | 2 Jahre | |
| Stephen Buckley | M | 74 | - | |
| Vuong Trieu | M | 59 | 1 Jahre | |
| Mustapha Bakali | M | 62 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 6 Jahre |
| Thomas D. Szucs | M | 64 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 Jahre |
| Matthew Ronsheim | M | 52 | 3 Jahre | |
| James Sulat | M | 73 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 Jahre |
| Carolyn Beaver | F | 66 | 4 Jahre | |
| Richard Alan Lerner | M | 85 | 9 Jahre | |
| David Poorvin | M | 76 | 10 Jahre | |
| Charles P. Slacik | M | 70 | 5 Jahre | |
| Michel Gréco | M | 80 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 Jahre |
| Robert DiTullio | M | 70 | 1 Jahre | |
| Harry Stylli | M | 62 | 4 Jahre | |
| David Pendarvis | M | 65 | 7 Jahre | |
| Jane Hsaio | M | 77 | 3 Jahre | |
| Myla Lai-Goldman | M | 66 | 4 Jahre | |
| Dave Henderson | M | - | - | |
| Robin G. Weiner | F | 68 | - | |
| Hariolf Kottmann | M | 69 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | - |
| Allan T. Bombard | M | 71 | 5 Jahre | |
| Clarke Neumann | M | 60 | 15 Jahre | |
| Celia Eckert | F | 52 | 2 Jahre | |
| Markus Beck | M | 60 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | - |
| Lawrence R. Moreau | M | 81 | - | |
| Alisa Judge | F | 68 | - | |
| Angelica Kohlmann | M | 64 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | 2 Jahre |
| Sudipto Sur | M | - | 3 Jahre | |
| Miguel F. E S. de Quintanilha Mantas | M | 63 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | - |
| Mathias Ehrich | M | - | - | |
| Charlie Rodi | M | - | 3 Jahre | |
| George Uy | M | 67 | 2 Jahre | |
| Dieter Peters | M | 68 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | - |
| Larry E. Lenig | M | 75 | 1 Jahre | |
| Joerg Grasser | M | 49 | 1 Jahre | |
| Zhenwei Miao | M | 60 | 3 Jahre | |
| Karsten Schmidt | M | 62 | - | |
| Patrick Enright | M | 62 | 1 Jahre | |
| Amar P. Singh | M | 65 | - | |
| Robert J. Koehler | M | 75 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | 20 Jahre |
| Stephen L. Zaniboni | M | 65 | 8 Jahre | |
| John E. Lucas | M | 90 | 8 Jahre | |
| Paul W. Hawran | M | 71 | 3 Jahre | |
| Axel Bolte | M | 52 | 8 Jahre | |
| Dan Kisner | M | 77 | - | |
| Larry M. Myres | M | 65 | - | |
| Brian Baker | M | 57 | - | |
| Gregory Glenn | M | 70 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 Jahre |
| Robin M. Jackman | M | 54 | - | |
| Shawn M. Marcell | M | 62 | - | |
| Klaus Sturany | M | 77 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | 19 Jahre |
| Fareed Kureshy | M | 81 | 2 Jahre | |
| Daniel J. Levitt | M | 76 | - | |
| Jeffrey Otto | M | - | - | |
| Michael Alexander Monko | M | 64 | - | |
| Diane D. S. Tang-Liu | M | 67 | - | |
| Gary S. Riordan | M | 65 | - | |
| Steven Owings | M | 71 | 2 Jahre | |
| Kathleen M. Wiltsey | F | 68 | - | |
| Martina Flöel | M | 64 |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | - |
| Shishir Sinha | M | 57 | 3 Jahre | |
| Dereck A. Tatman | M | 51 | - | |
| Elizabeth Dragon | M | 75 | 3 Jahre | |
| Yujiro Hata | M | 49 | 8 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 80 | 80,00% |
| Deutschland | 11 | 11,00% |
| Österreich | 8 | 8,00% |
| Schweiz | 1 | 1,00% |
| Frankreich | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ernst-Günter Afting
- Persönliches Netzwerk
